Generation and Respiratory Deposition of Therapeutic Aerosols1,2

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The American review of respiratory disease

• Publication date

  2015-05-14

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1164/ARRD.1980.122.5P2.71
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Factors Affecting Aerosol Deposition in Critically Ill Patient

  2021cites this paper
• Inhaled Cisplatin for NSCLC: Facts and Results

  2019cites this paper
• Inhaled chemotherapy adverse effects: mechanisms and protection methods

  2019cites this paper
• Airborne microplastics: a review study on method for analysis, occurrence, movement and risks

  2019cites this paper
• Airborne microplastics: Consequences to human health?

  2018cites this paper
• Newer devices and improved formulations of inhaled insulin

  2015cites this paper
• 66 – Aerosols and Aerosol Drug Delivery Systems

  2014cites this paper
• The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy

  2014cites this paper
• Defense mechanisms of the respiratory system and aerosol production systems.

  2014cites this paper
• Development and validation of an attenuated Mycoplasma hyopneumoniae aerosol vaccine.

  2013cites this paper
• Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.

  2013cites this paper